{"id":"https://openalex.org/W7204728153","doi":"https://doi.org/10.1016/s2152-2650(26)02570-x","title":"ABCL-536: Complete Metabolic Responses to Checkpoint Inhibitor Therapy in Patients With PD-L1\u2013Enriched Relapsed/Refractory DLBCL Ineligible for Intensive Therapy: A Real-World Case Series From an LMIC Tertiary Center","display_name":"ABCL-536: Complete Metabolic Responses to Checkpoint Inhibitor Therapy in Patients With PD-L1\u2013Enriched Relapsed/Refractory DLBCL Ineligible for Intensive Therapy: A Real-World Case Series From an LMIC Tertiary Center","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204728153","doi":"https://doi.org/10.1016/s2152-2650(26)02570-x"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02570-x","doi":"https://doi.org/10.1016/s2152-2650(26)02570-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02570-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031092722","display_name":"Jerryes Pious Wisely","orcid":"https://orcid.org/0000-0003-0766-6713","observed_orcids":["https://orcid.org/0000-0003-0766-6713"]},"institutions":[{"id":"https://openalex.org/I4210108369","display_name":"Fortis Memorial Research Institute","ror":"https://ror.org/01h7phh70","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210108369"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Jerryes Pious Wisely","raw_affiliation_strings":["Fortis Memorial Research Institute, Gurugaon, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fortis Memorial Research Institute, Gurugaon, India","institution_ids":["https://openalex.org/I4210108369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031032662","display_name":"Ashutosh Jain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108369","display_name":"Fortis Memorial Research Institute","ror":"https://ror.org/01h7phh70","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210108369"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashutosh Jain","raw_affiliation_strings":["Fortis Memorial Research Institute, Gurugaon, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fortis Memorial Research Institute, Gurugaon, India","institution_ids":["https://openalex.org/I4210108369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117597448","display_name":"Punam Rabha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108369","display_name":"Fortis Memorial Research Institute","ror":"https://ror.org/01h7phh70","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210108369"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Punam Rabha","raw_affiliation_strings":["Fortis Memorial Research Institute, Gurugaon, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fortis Memorial Research Institute, Gurugaon, India","institution_ids":["https://openalex.org/I4210108369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147085685","display_name":"Kilitoli Chophy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108369","display_name":"Fortis Memorial Research Institute","ror":"https://ror.org/01h7phh70","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210108369"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kilitoli Chophy","raw_affiliation_strings":["Fortis Memorial Research Institute, Gurugaon, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fortis Memorial Research Institute, Gurugaon, India","institution_ids":["https://openalex.org/I4210108369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068265490","display_name":"Narendra Kumar Bhardwaj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108369","display_name":"Fortis Memorial Research Institute","ror":"https://ror.org/01h7phh70","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210108369"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Narendra Bhardwaj","raw_affiliation_strings":["Fortis Memorial Research Institute, Gurugaon, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fortis Memorial Research Institute, Gurugaon, India","institution_ids":["https://openalex.org/I4210108369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075760277","display_name":"Brij Bhushan Tyagi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108369","display_name":"Fortis Memorial Research Institute","ror":"https://ror.org/01h7phh70","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210108369"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Brij Bhushan Tyagi","raw_affiliation_strings":["Fortis Memorial Research Institute, Gurugaon, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fortis Memorial Research Institute, Gurugaon, India","institution_ids":["https://openalex.org/I4210108369"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5147102408","display_name":"Vinod Raina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108369","display_name":"Fortis Memorial Research Institute","ror":"https://ror.org/01h7phh70","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210108369"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vinod Raina","raw_affiliation_strings":["Fortis Memorial Research Institute, Gurugaon, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fortis Memorial Research Institute, Gurugaon, India","institution_ids":["https://openalex.org/I4210108369"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210108369"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.66135648,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S908","last_page":"S909"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-diffuse-large-b-cell-lymphoma","display_name":"relapsed/refractory diffuse large B-cell lymphoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pd-l1-combined-positive-score","display_name":"PD-L1 combined positive score","score":0.7390000224113464},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8059999942779541},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/complete-metabolic-response","display_name":"complete metabolic response","score":0.9879999756813049},{"id":"https://openalex.org/keywords/frailty","display_name":"frailty","score":0.5189999938011169},{"id":"https://openalex.org/keywords/chemotherapy-ineligible-patients","display_name":"chemotherapy-ineligible patients","score":0.6930000185966492},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.5},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.44699999690055847},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.44999998807907104},{"id":"https://openalex.org/keywords/low-and-middle-income-countries","display_name":"low- and middle-income countries","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9711999893188477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5885000228881836},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5764999985694885},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.5051000118255615},{"id":"https://openalex.org/C143724316","wikidata":"https://www.wikidata.org/wiki/Q312468","display_name":"Series (stratigraphy)","level":2,"score":0.3483000099658966},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3212999999523163},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.26750001311302185},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.2581999897956848},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2492000013589859},{"id":"https://openalex.org/C2991842025","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Tertiary care","level":2,"score":0.2222999930381775}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02570-x","doi":"https://doi.org/10.1016/s2152-2650(26)02570-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02570-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2904728595","https://openalex.org/W2977621685","https://openalex.org/W2987155128","https://openalex.org/W7108465987","https://openalex.org/W4310103706","https://openalex.org/W4200188834","https://openalex.org/W4411102870","https://openalex.org/W2909334052","https://openalex.org/W4405039489","https://openalex.org/W3094939491"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2026-08-31T00:00:00"}